{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Cefixime  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Cefixime. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Cefixime  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "cefixime",
    "trial_2_text": "Cefixime  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Cefixime Supplement: 60 participants will take Cefixime 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Cefixime. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Cefixime  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.1839410811662674,
      "123": 0.16028623282909393,
      "78": 0.1493830382823944,
      "9": 0.13985316455364227,
      "177": 0.13771170377731323,
      "17": 0.10852016508579254,
      "173": 0.10411014407873154,
      "20": 0.10104872286319733,
      "49": 0.10060621052980423,
      "14": 0.09960117191076279,
      "37": 0.09684980660676956,
      "2": 0.09142150729894638,
      "68": 0.09003861248493195,
      "21": 0.0897819995880127,
      "180": 0.08651664108037949,
      "61": 0.08483567833900452,
      "76": 0.08430607616901398,
      "189": 0.08221577852964401,
      "188": 0.07481180131435394,
      "46": 0.0737128034234047,
      "114": 0.07312473654747009,
      "29": 0.07293129712343216,
      "350": 0.07082923501729965,
      "30": 0.07047880440950394,
      "77": 0.06933462619781494,
      "151": 0.0641179233789444,
      "228": 0.0637766644358635,
      "269": 0.0631910189986229,
      "35": 0.061104532331228256,
      "147": 0.05957518890500069,
      "64": 0.056129224598407745,
      "200": 0.055791016668081284,
      "85": 0.053852587938308716,
      "67": 0.052451733499765396,
      "142": 0.05173241347074509,
      "126": 0.05129352957010269,
      "249": 0.051028814166784286,
      "179": 0.0509711429476738,
      "27": 0.05093222111463547,
      "79": 0.0494709238409996,
      "396": 0.04931309446692467,
      "276": 0.04890387877821922,
      "193": 0.04666757211089134,
      "130": 0.04441190883517265,
      "194": 0.04325757175683975,
      "1": 0.04264795035123825,
      "144": 0.0420815646648407,
      "243": 0.04124375060200691,
      "101": 0.040864843875169754,
      "96": 0.04006754606962204,
      "131": 0.03921281918883324,
      "164": 0.03873390331864357,
      "261": 0.03795561566948891,
      "104": 0.03721630573272705,
      "86": 0.03701029717922211,
      "234": 0.03695334866642952,
      "361": 0.03681037575006485,
      "28": 0.035773515701293945,
      "72": 0.0355275496840477,
      "5": 0.03526103124022484,
      "122": 0.03488003462553024,
      "69": 0.034724194556474686,
      "239": 0.034382790327072144,
      "170": 0.03429213911294937,
      "253": 0.033951032906770706,
      "186": 0.03349842503666878,
      "191": 0.03217516466975212,
      "288": 0.03149823099374771,
      "75": 0.031229598447680473,
      "282": 0.03002062439918518,
      "133": 0.030011100694537163,
      "121": 0.02973587065935135,
      "18": 0.029524659737944603,
      "102": 0.029269549995660782,
      "441": 0.028501277789473534,
      "82": 0.027455776929855347,
      "494": 0.027368947863578796,
      "183": 0.026157623156905174,
      "31": 0.026141345500946045,
      "38": 0.02521139197051525,
      "268": 0.024087941274046898,
      "286": 0.023885855451226234,
      "132": 0.02334938757121563,
      "221": 0.023183288052678108,
      "356": 0.023086290806531906,
      "92": 0.023045001551508904,
      "116": 0.022924676537513733,
      "355": 0.022745097056031227,
      "262": 0.02260158583521843,
      "154": 0.02243727818131447,
      "100": 0.02189306728541851,
      "398": 0.02157539688050747,
      "4": 0.02157021313905716,
      "138": 0.021336279809474945,
      "256": 0.020414531230926514,
      "202": 0.020038360729813576,
      "15": 0.019810715690255165,
      "139": 0.019753560423851013,
      "390": 0.0197331253439188,
      "713": 0.01963883452117443
    },
    "trial_2_ae": {
      "87": 0.1839410811662674,
      "123": 0.16028623282909393,
      "78": 0.1493830382823944,
      "9": 0.13985316455364227,
      "177": 0.13771170377731323,
      "17": 0.10852016508579254,
      "173": 0.10411014407873154,
      "20": 0.10104872286319733,
      "49": 0.10060621052980423,
      "14": 0.09960117191076279,
      "37": 0.09684980660676956,
      "2": 0.09142150729894638,
      "68": 0.09003861248493195,
      "21": 0.0897819995880127,
      "180": 0.08651664108037949,
      "61": 0.08483567833900452,
      "76": 0.08430607616901398,
      "189": 0.08221577852964401,
      "188": 0.07481180131435394,
      "46": 0.0737128034234047,
      "114": 0.07312473654747009,
      "29": 0.07293129712343216,
      "350": 0.07082923501729965,
      "30": 0.07047880440950394,
      "77": 0.06933462619781494,
      "151": 0.0641179233789444,
      "228": 0.0637766644358635,
      "269": 0.0631910189986229,
      "35": 0.061104532331228256,
      "147": 0.05957518890500069,
      "64": 0.056129224598407745,
      "200": 0.055791016668081284,
      "85": 0.053852587938308716,
      "67": 0.052451733499765396,
      "142": 0.05173241347074509,
      "126": 0.05129352957010269,
      "249": 0.051028814166784286,
      "179": 0.0509711429476738,
      "27": 0.05093222111463547,
      "79": 0.0494709238409996,
      "396": 0.04931309446692467,
      "276": 0.04890387877821922,
      "193": 0.04666757211089134,
      "130": 0.04441190883517265,
      "194": 0.04325757175683975,
      "1": 0.04264795035123825,
      "144": 0.0420815646648407,
      "243": 0.04124375060200691,
      "101": 0.040864843875169754,
      "96": 0.04006754606962204,
      "131": 0.03921281918883324,
      "164": 0.03873390331864357,
      "261": 0.03795561566948891,
      "104": 0.03721630573272705,
      "86": 0.03701029717922211,
      "234": 0.03695334866642952,
      "361": 0.03681037575006485,
      "28": 0.035773515701293945,
      "72": 0.0355275496840477,
      "5": 0.03526103124022484,
      "122": 0.03488003462553024,
      "69": 0.034724194556474686,
      "239": 0.034382790327072144,
      "170": 0.03429213911294937,
      "253": 0.033951032906770706,
      "186": 0.03349842503666878,
      "191": 0.03217516466975212,
      "288": 0.03149823099374771,
      "75": 0.031229598447680473,
      "282": 0.03002062439918518,
      "133": 0.030011100694537163,
      "121": 0.02973587065935135,
      "18": 0.029524659737944603,
      "102": 0.029269549995660782,
      "441": 0.028501277789473534,
      "82": 0.027455776929855347,
      "494": 0.027368947863578796,
      "183": 0.026157623156905174,
      "31": 0.026141345500946045,
      "38": 0.02521139197051525,
      "268": 0.024087941274046898,
      "286": 0.023885855451226234,
      "132": 0.02334938757121563,
      "221": 0.023183288052678108,
      "356": 0.023086290806531906,
      "92": 0.023045001551508904,
      "116": 0.022924676537513733,
      "355": 0.022745097056031227,
      "262": 0.02260158583521843,
      "154": 0.02243727818131447,
      "100": 0.02189306728541851,
      "398": 0.02157539688050747,
      "4": 0.02157021313905716,
      "138": 0.021336279809474945,
      "256": 0.020414531230926514,
      "202": 0.020038360729813576,
      "15": 0.019810715690255165,
      "139": 0.019753560423851013,
      "390": 0.0197331253439188,
      "713": 0.01963883452117443
    }
  },
  "safety": {
    "trial_1_safety": 0.2988484501838684,
    "trial_2_safety": 0.2988484501838684
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.479208379983902
  }
}